Intercontinental Wealth Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Intercontinental Wealth Advisors's DGX Position: Q2 2023 in Review
Intercontinental Wealth Advisors reduced its Quest Diagnostics (DGX) stake by 2.3% in Q2 2023, selling an estimated $8.27K and leaving 2,564 shares worth $360K. The position accounts for 0.09% of the portfolio, ranked #233.
Intercontinental Wealth Advisors first reported a position in DGX in Q1 2020 and has held it in 14 quarters since. The position peaked at $912K in Q2 2020. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Intercontinental Wealth Advisors held 2,564 shares of Quest Diagnostics worth $360K as of Q2 2023.
- Intercontinental Wealth Advisors sold 60 Quest Diagnostics shares in Q2 2023, an estimated $8.27K.
- Quest Diagnostics made up 0.09% of Intercontinental Wealth Advisors's portfolio in Q2 2023, its #233 holding.
- Intercontinental Wealth Advisors first reported a position in Quest Diagnostics in Q1 2020 and has held it in 14 quarters since.
- Intercontinental Wealth Advisors's Quest Diagnostics position peaked at $912K in Q2 2020.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Intercontinental Wealth Advisors's 13F filing for Q2 2023, filed 21 Jul 2023.